REQUEST A DEMO
Total
USD $0.00
Search more companies

PharmaPark Production OU (Estonia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PharmaPark Production OU Profile Updated: September 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

PharmaPark Production OU is an enterprise in Estonia, with the main office in Tallinn. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. PharmaPark Production OU was incorporated on May 02, 2023. From the latest financial highlights, PharmaPark Production OU reported a net sales revenue increase of 294.91% in 2025. During that time, PharmaPark Production OU’s total assets grew by 535%. In, 2025, the company’s net profit margin increased by 171.35%.

Headquarters
Nuia tn 2 Lasnamae linnaosa
Tallinn; Harju county; Postal Code: 11415

Contact Details: Purchase the PharmaPark Production OU report to view the information.

Basic Information
Registered Capital:
Purchase the PharmaPark Production OU report to view the information.
Financial Auditors:
Purchase the PharmaPark Production OU report to view the information.
Incorporation Date:
May 02, 2023
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after PharmaPark Production OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
294.91%▲
Total Operating Revenue
294.91%▲
Operating Profit
-34.99%▼
EBITDA
-27.81%▼
Net Profit/Loss for the Period
-36.88%▼
Total Assets
535%▲
Total Equity
N/A
Operating Profit Margin
169.28%▲
Net Profit Margin
171.35%▲
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?